Abstract |
Fundamental and clinical studies were made on T-1982 ( cefbuperazone) and the results were obtained as follows. Serum and uterine tissue concentrations of T-1982 were determined at 26 minutes before and at 20 to 80 minutes after the completion of intravenous drip infusion of 1 g. The levels of T-1982 in the fallopian tube, ovarium, endometrium, myometrium and uterine cervix were 23.7, 19.5, 50.5, 10.9 micrograms/g and 17.5 micrograms/g at 20 minutes after the completion of infusion. The levels were sufficiently effective against major pathogens (Gram negative bacteria and anaerobic bacilli) isolated in the field of obstetrics and gynecology. T-1982 was administered to 11 patients, including 7 of acute adnexitis, each one of pelveoperitonitis, pyometra, puerperal fever, and 1 of puerperal fever with sepsis, at a dose of 1-2 g twice a day for a period of 5 to 9 days by intravenous injection or intravenous drip infusion. Clinical responses were excellent in 5, good in 3 and poor in 3. No adverse reactions nor marked changes in laboratory findings were observed in any of the cases treated with T-1982.
|
Authors | H Nakamura, Y Iwata, S Hayashi |
Journal | The Japanese journal of antibiotics
(Jpn J Antibiot)
Vol. 36
Issue 5
Pg. 956-62
(May 1983)
ISSN: 0368-2781 [Print] Japan |
PMID | 6684699
(Publication Type: Journal Article)
|
Chemical References |
- Cephamycins
- cefbuperazone
|
Topics |
- Adolescent
- Adult
- Aged
- Cephamycins
(analysis, therapeutic use)
- Female
- Humans
- Middle Aged
- Ovary
(analysis, blood supply)
- Pelvic Inflammatory Disease
(drug therapy)
- Pregnancy
- Puerperal Infection
(drug therapy)
- Uterus
(analysis)
|